Skip Navigation
Search

Recent Publications

Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613 Moises O. Guardado Rivas ,Shawn D. Stuart ,Daniel Thach,Michael Dahan, Robert Shorr, Zuzana Zachar, Paul M. Bingham 
Published: June 8, 2022